Erlec1-KO Mouse
Common Name
Erlec1-KO
제품 ID
S-KO-11895
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-66753-Erlec1-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Erlec1-KO Mouse (카탈로그 번호 S-KO-11895)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Erlec1-KO
품종 계통계통 ID
KOCMP-66753-Erlec1-B6J-VA
유전자명
제품 ID
S-KO-11895
유전자 별칭
4933407N01Rik
배경
C57BL/6JCya
유전자 공식 전체 명칭
endoplasmic reticulum lectin 1
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 11
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000073192
NCBI 전사체 ID
NM_025745
타겟 영역
Exon 3~11
유효 영역 크기
~13.0 kb
유전자 연구 개요
Erlec1, also known as endoplasmic reticulum lectin 1, is likely involved in the endoplasmic reticulum-associated degradation (ERAD) pathway as SEL1L recruits it to form a functional HRD1 ERAD complex [9]. It may also respond to endoplasmic reticulum stress as its gene expression can be induced by ER stressors in certain cell lines [7].
In Class III malocclusion, a rare heterozygous variant in Erlec1 was identified. This gene is highly expressed in mouse jaw osteoblasts and inhibits osteoblast proliferation, with the identified variant significantly enhancing this inhibitory effect. Also, the proper level of Erlec1 expression is crucial for proper osteogenic differentiation, suggesting it plays a role in the genetic basis of Class III malocclusion [1].
In a Mendelian randomization study, a 1 standard deviation increase in the ERLEC1-201-to-ERLEC1-202 splice variant ratio was associated with a reduced risk of schizophrenia [2]. Additionally, in a study exploring the gut-bladder axis, Erlec1 was identified as one of the hub genes differentially expressed between interstitial cystitis patients and healthy individuals, representing a potential therapeutic target [3]. In the context of genetic overlap between schizophrenia and constipation, Erlec1 was among the mapped genes [4]. A Mendelian randomization analysis also found that ERLEC1 in plasma was positively associated with intelligence and cognitive performance [5].
In prostate cancer, FBXL4 potentially controls cancer metastasis through regulation of ERLEC1 levels [6]. In a mouse model of cancer-related cognitive impairment, Erlec1 expression was upregulated in the brains of mice treated with concurrent hindlimb radiation and doxorubicin compared to control brains [8].
In summary, Erlec1 is involved in multiple biological processes and disease conditions. Its role in osteoblast proliferation and differentiation is significant for Class III malocclusion. Its associations with schizophrenia, interstitial cystitis, and cognitive performance also highlight its importance in neurological-related conditions. Additionally, its potential link to cancer metastasis in prostate cancer and its expression changes in a cancer-treatment-related cognitive impairment model further emphasize its diverse functions in disease. The study of Erlec1 using various research models helps to better understand its functions in these disease areas.
References:
1. Rao, Chunbao, Guan, Biyang, Luo, Dong, Zhong, Baimao, Lu, Xiaomei. 2020. Identification of pathogenic variants of ERLEC1 in individuals with Class III malocclusion by exome sequencing. In Human mutation, 41, 1435-1446. doi:10.1002/humu.24054. https://pubmed.ncbi.nlm.nih.gov/32442352/
2. Lu, Tianyuan, Forgetta, Vincenzo, Greenwood, Celia M T, Zhou, Sirui, Richards, J Brent. 2022. Circulating Proteins Influencing Psychiatric Disease: A Mendelian Randomization Study. In Biological psychiatry, 93, 82-91. doi:10.1016/j.biopsych.2022.08.015. https://pubmed.ncbi.nlm.nih.gov/36280454/
3. Fu, Chaowei, Zhao, Yu, Zhou, Xiang, Liu, Fengping, Feng, Ninghan. 2024. Gut microbiota and interstitial cystitis: exploring the gut-bladder axis through mendelian randomization, biological annotation and bulk RNA sequencing. In Frontiers in immunology, 15, 1395580. doi:10.3389/fimmu.2024.1395580. https://pubmed.ncbi.nlm.nih.gov/39399486/
4. Luo, Qinghua, An, Mingwei, Wu, Yunxiang, Zhang, Leichang, Wang, Chen. 2025. Genetic overlap between schizophrenia and constipation: insights from a genome-wide association study in a European population. In Annals of general psychiatry, 24, 11. doi:10.1186/s12991-025-00551-3. https://pubmed.ncbi.nlm.nih.gov/40033405/
5. Zhao, Wei, Zhang, Xinyu, Li, Feng, Yan, Cheng. 2024. Mendelian Randomization Estimates the Effects of Plasma and Cerebrospinal Fluid Proteins on Intelligence, Fluid Intelligence Score, and Cognitive Performance. In Molecular neurobiology, 62, 4922-4934. doi:10.1007/s12035-024-04542-5. https://pubmed.ncbi.nlm.nih.gov/39495227/
6. Stankiewicz, Elzbieta, Mao, Xueying, Mangham, D Chas, Berney, Daniel M, Lu, Yong-Jie. 2017. Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer. In Scientific reports, 7, 5124. doi:10.1038/s41598-017-05209-z. https://pubmed.ncbi.nlm.nih.gov/28698647/
7. Misiewicz, Michael, Déry, Marc-André, Foveau, Bénédicte, Ruths, Derek, LeBlanc, Andréa C. 2013. Identification of a novel endoplasmic reticulum stress response element regulated by XBP1. In The Journal of biological chemistry, 288, 20378-91. doi:10.1074/jbc.M113.457242. https://pubmed.ncbi.nlm.nih.gov/23737521/
8. Demos-Davies, Kimberly, Lawrence, Jessica, Ferreira, Clara, Seelig, Davis. 2023. The Distant Molecular Effects on the Brain by Cancer Treatment. In Brain sciences, 14, . doi:10.3390/brainsci14010022. https://pubmed.ncbi.nlm.nih.gov/38248237/
9. Lin, Liangguang Leo, Wei, Xiaoqiong, Wang, Huilun Helen, Sun, Shengyi, Qi, Ling. 2023. SEL1L-HRD1 interaction is prerequisite for the formation of a functional HRD1 ERAD complex. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.04.13.536796. https://pubmed.ncbi.nlm.nih.gov/37333389/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
